Evidence map›Paper›PMID 38934121›Full record

ArticleEuropean journal of translational myology2024

Onychocryptosis: a retrospective study of clinical aspects, inflammation treatment and pain management using Ozoile as a hydrogel and cream formulation.

Vincenzo Francavilla, Giuseppe Secolo, Marianna D'Armetta, Rosario Toscano, Angelo Campo, Valentina Catanzaro, Marina Manno, Innocenzo Secolo, Giuseppe Messina

Abstract read
In one paragraph

Article in European journal of translational myology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. OZOILEEuropean journal of translational myology · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Vincenzo FrancavillaFaculty of Medicine and Surgery, University Kore, Enna. vincenzo.francavilla@unikore.it.
Giuseppe SecoloFaculty of Medicine and Pharmacy, University Dunarea de Jos, Galati. g.secolo@hotmail.it.
Marianna D'ArmettaA.O.U.Policlinico P. Giaccone, Palermo. darmetta.m@gmail.com.
Rosario ToscanoStudio di Podologia Dott. Toscano Rosario Emanuele, Viagrande, Catania. dr.toscanorosario@icloud.com.
Angelo CampoStudio di podologia Dott. Campo Angelo, Pozzallo, Ragusa. podologia.campo@gmail.com.
Valentina CatanzaroStudio Podologico Catanzaro, Siracusa. valecata82@gmail.com.
Marina MannoStudio Dr.ssa Manno Marina, Palermo. mannomarina70@gmail.com.
Innocenzo SecoloCentro Ortopedico Kineo, Catania. studiosecolo1967@libero.it.
Giuseppe MessinaDepartment of Human Sciences and Promotion of the Quality of Life San Raffaele University, Rome. giuseppe.messina@uniroma5.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ingrown toenails account for roughly 20% of all foot problems in primary care. It is most common in young men, with nail care habits and footwear being major contributors. Onychocryptosis is typically caused by self-treatment attempts to cure the condition in its early stages. Its clinical features are frequently confused with other osseous and soft tissue abnormalities. The goal of this study was to provide perspectives on the management of pain and inflammation in Onychocryptosis using an Ozoile-based hydrogel formulation in a semi-occlusive bandage for 14 days, while incorporating natural pharmacological solutions into established protocols. The primary outcomes measured were pain reduction on NRS and stadiation according to the Al Kline Classification. The reduction was statistically significant, with a mean decrease in VAS score from 10 to 4 (p < 0.05), and Al Kline classification decreased by an average of 1.6 stages. 42% of patients recovered within the first 15 days of treatment, and 93% by the end of the scheduled treatment.

Identifiers

PMID38934121
PMCPMC11264223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.